Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor

Clin J Am Soc Nephrol. 2022 May;17(5):628-630. doi: 10.2215/CJN.03250322. Epub 2022 Apr 28.
No abstract available

Keywords: COVID-19; GFR; SARS-CoV-2; SGLT2; acute kidney injury; dapagliflozin; pandemic; safety; sodium-glucose cotransporter 2.

Publication types

  • Editorial
  • Kommentar

MeSH terms

  • Benzhydryl Compounds
  • COVID-19*
  • Glucosides
  • Humans
  • Kidney / drug effects
  • Paint
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Sodium-Glucose Transporter 2 Inhibitors
  • dapagliflozin